🇺🇸 FDA
Patent

US 8236835

Heterocyclic inhibitors of stearoyl-CoA desaturase

granted A61PA61P17/00A61P17/02

Quick answer

US patent 8236835 (Heterocyclic inhibitors of stearoyl-CoA desaturase) held by Xenon Pharmaceuticals Inc. expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P17/00, A61P17/02, A61P17/04, A61P17/06